According to new research published in Thorax, the use of non-invasive breathing support to treat patients with moderate to severe COVID-19 in hospitals isn’t linked to a heightened risk of transmitting the infection to others.
One of the world’s largest producers of respiratory medical devices, Philips, took a striking financial hit during the last quarter with revenue dropping 7.6% percent from the previous year.
The randomized, placebo-controlled segment of the study showed that AD109 had a statistically significant and clinically meaningful difference from placebo after a single dose in the patients’ hypoxic burden.
The survival rate gap remained significant when accounting for patients’ ages, overall health, other pre-existing conditions, and causes of death.
ChiliSleep and Ebb Therapeutics join forces. Ebb’s largest investor led a $37 million investment to accelerate the merged company’s growth.
The team will examine whether combining 40-Hz flashes (to increase gamma waves) with a light therapy designed to reset a patient’s sleep-wake cycle may help.
The primary endpoint will be the frequency of cataplexy attacks. Other symptoms of narcolepsy as well as safety will also be assessed.
It is an update to the AASM’s 2010 guideline, which made recommendations for specific surgical procedures but did not address when to consider such options.
OptumRx will offer and administer standard pharmacy benefit coverage for members who choose to add the product to their formularies.